Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei Shir

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|September 3, 2002
Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKRAlexei Shir, Alexander Levitzki
Seminars in Cancer Biology|October 18, 2003
Tumor specific activation of PKR as a non-toxic modality of cancer treatmentAlexei Shir, Inbar Friedrich, Alexander Levitzki
Current Opinion in Pharmacology|May 8, 2013
Targeted cancer immunotherapyMaya Zigler, Alexei Shir, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Plos Medicine|December 2, 2005
EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in miceAlexei Shir, Manfred Ogris, Ernst Wagner, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Nucleic acid-based therapeutics for glioblastomaAlexei Shir, Alexander Levitzki, Ernst Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2011
EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in miceAlexei Shir, Manfred Ogris, Wolfgang Roedl, et al.
Cell|February 8, 2002
Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKRYitzhak Ben-Asouli, Yona Banai, Yehuda Pel-Or, et al.
IUBMB Life|February 25, 2012
PolyIC GE11 polyplex inhibits EGFR-overexpressing tumorsGalith Abourbeh, Alexei Shir, Eyal Mishani, et al.
Pharmaceutical Research|August 10, 2010
Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrierDavid Schaffert, Melinda Kiss, Wolfgang Rödl, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|September 3, 2002
Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKRAlexei Shir, Alexander Levitzki
Seminars in Cancer Biology|October 18, 2003
Tumor specific activation of PKR as a non-toxic modality of cancer treatmentAlexei Shir, Inbar Friedrich, Alexander Levitzki
Current Opinion in Pharmacology|May 8, 2013
Targeted cancer immunotherapyMaya Zigler, Alexei Shir, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Plos Medicine|December 2, 2005
EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in miceAlexei Shir, Manfred Ogris, Ernst Wagner, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Nucleic acid-based therapeutics for glioblastomaAlexei Shir, Alexander Levitzki, Ernst Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2011
EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in miceAlexei Shir, Manfred Ogris, Wolfgang Roedl, et al.
Cell|February 8, 2002
Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKRYitzhak Ben-Asouli, Yona Banai, Yehuda Pel-Or, et al.
IUBMB Life|February 25, 2012
PolyIC GE11 polyplex inhibits EGFR-overexpressing tumorsGalith Abourbeh, Alexei Shir, Eyal Mishani, et al.
Pharmaceutical Research|August 10, 2010
Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrierDavid Schaffert, Melinda Kiss, Wolfgang Rödl, et al.
Pageof 2